Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2022-11-14 Director's Dealing
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-11-14 English
FORM 4
Director's Dealing
2022-11-09 English
FORM 4
Director's Dealing
2022-11-01 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-01 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 1, 2022, reporting the announcement of financial results for the quarter ended September 30, 2022. It includes a press release as Exhibit 99.1 titled 'IDEXX Laboratories Announces Third Quarter Results.' The text explicitly states this is a current report furnishing results of operations and financial condition under Item 2.02, which corresponds to an earnings release. The document is relatively short (3783 characters) and primarily serves to announce the earnings results rather than providing a full detailed financial report or transcript. Therefore, this filing is best classified as an Earnings Release (ER).
2022-11-01 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details an amendment to a credit agreement, including borrowing terms, interest rates, and covenants. This is an update on the company's financing arrangements, specifically a material definitive agreement related to credit facilities. It is not a full financial report, earnings release, or management discussion, but rather a financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2022-10-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.